Medicalgorithmics Achieves $1.3M Annualized Recurring Revenue from the U.S.
Medicalgorithmics, a medtech company listed on the sWIG80 index, generated over $110,000 (approximately 440,000 PLN) in November from AI service sales to clients in the U.S. Independent Diagnostic Testing Facility (IDTF) market, resulting in $1.3 million in annualized revenue from five new clients. This milestone delivers on the company’s May 2024 projections for growth in the U.S. market. The increasing revenue stream highlights the value of Medicalgorithmics’ technology – earlier this year, the Warsaw Stock Exchange-listed medtech had zero revenue from the U.S. market. Following its strategy, the company is negotiating further agreements with potential new clients, including major U.S. partners.